QA: Genomic Health INC in us_health_services/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001131324_2017_Genomic_Health_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning No stock price available subcommand.plot {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001131324')"}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001131324, Genomic Health INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 9,462,000
2 AssetsCurrent 145,964,000
3 PropertyPlantAndEquipment 45,688,000
4 remainder_Assets 0
5 LongTermLiabilities 0
6 LiabilitiesCurrent 41,175,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 73,272,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 151,042,000
15 ResearchAndDevelopmentExpense 61,723,000
16 remainder_Expenses 58,644,000
17 remainder_Revenues 327,868,000
18 remainder_NetIncome 2,894,000
19 remainder_ComprehensiveNetIncome -1,554,000
  yvar yval
0 Assets 201,114,000
1 Liabilities 41,175,000
2 Expenses 344,681,000
3 Revenues 327,868,000
4 StockholdersEquity 159,939,000
5 NetIncome -13,919,000
6 ComprehensiveNetIncome -15,473,000
7 BaseVar 459,643,000
8 EconomicCapitalRatio 3.54

Edgar->Model Mapping

Feature Distribution

Change over Time